Contact this trialFirst, we need to learn more about you.
Atypical Antipsychotic
AL-NCD +2 More for Schizoaffective Disorder
Recruiting5 awardsPhase 4
Los Angeles, California
This trial will compare the effectiveness of two forms of aripiprazole in preventing the return of psychotic symptoms in patients who have recently developed schizophrenia.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.